Vaborbactam is a boronic acid-based beta-lactamase inhibitor used in combination with carbapenem antibiotics to treat complicated urinary tract infections and infections caused by multidrug-resistant Gram-negative… Read more













Vaborbactam is a boronic acid-based beta-lactamase inhibitor used in combination with carbapenem antibiotics to treat complicated urinary tract infections and infections caused by multidrug-resistant Gram-negative bacteria. This category provides access to high-quality reference standards essential for pharmaceutical development and rigorous quality control. Laboratories utilize these Vaborbactam materials, including defined process impurities and structural analogues, for impurity profiling and method validation to ensure the accuracy and safety of drug formulations. Additionally, the inclusion of stable isotope labelled compounds, such as deuterium-labelled variants, provides researchers with precise internal standards for quantifying drug concentration during bioanalytical procedures and pharmacokinetic studies. By supplying these critical analytical tools, the catalogue supports reliable testing and regulatory compliance throughout the manufacturing lifecycle of Vaborbactam-containing products.